NEW YORK, Oct. 23, 2015 /PRNewswire/ -- PositiveID Corp. (OTCQB: PSID) shares closed at $.0268 up 13.56% in yesterday's session. Trading volume was over three times the daily average at nearly 11 million shares. PSID shares have jumped 19% since closing at $.0025 this past Monday.
Interested parties will want to read our due diligence on PositiveID Corp. Get our due diligence report at the link below. There is no cost to read the full report.
http://bit.ly/--PSID_Due_Diligence
Copy and paste to browser may be required.
About PositiveID Corporation
PositiveID Corporation is a life sciences tools and diagnostics company that develops biological detection systems for point-of-need testing and America's homeland defense industry. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats and analyze biological samples.
About Small Cap Street
We make the connection between sophisticated investors and high quality public companies. An issuer of reports written by financial analysts who provide a straightforward assessment of the profiled company and have pledged to remain free of influence when writing research reports. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.
Safe Harbor Statement
This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for markets and the demand for products. Forward-looking statements are no guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. The Company refers interested persons to its most recent Annual Report on Form 10-K and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The company assumes no duty to update its forward-looking statements
Compliance Procedure
Content is researched, written and reviewed on a best-effort basis by a 3rd party research provider. However, we are only human and may make mistakes. This report was prepared for informational purposes only. A full disclaimer can be found by viewing the full analyst report. We do not hold any positions and have not been compensated in any form for this press release and coinciding reports. For more information and services provided beyond this press release please use contact information provided below. If you notice any errors or omissions, please notify us.
Source: Small Cap Street
Contact: editor@smallcapstreet.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/due-diligence-report-positiveid-to-acquire-thermomedics--small-cap-street-300165355.html
SOURCE Small Cap Street
